J. Jason Morton

1.5k total citations
19 papers, 621 citations indexed

About

J. Jason Morton is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Jason Morton has authored 19 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Jason Morton's work include Cancer Cells and Metastasis (4 papers), Pluripotent Stem Cells Research (3 papers) and Immunotherapy and Immune Responses (3 papers). J. Jason Morton is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Pluripotent Stem Cells Research (3 papers) and Immunotherapy and Immune Responses (3 papers). J. Jason Morton collaborates with scholars based in United States, Canada and United Kingdom. J. Jason Morton's co-authors include Antonio Jimeno, Yosef Refaeli, Gregory Bird, Stephen B. Keysar, Phuong N. Le, Xiao‐Jing Wang, Bettina Miller, Hilary Somerset, Tugs‐Saikhan Chimed and Cera Nieto and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

J. Jason Morton

19 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Jason Morton United States 14 316 281 144 136 77 19 621
Kanako Yuki Japan 9 309 1.0× 248 0.9× 113 0.8× 124 0.9× 133 1.7× 15 629
Joakim Karlsson Sweden 13 278 0.9× 272 1.0× 176 1.2× 120 0.9× 61 0.8× 24 572
Xuemin Lu United States 9 379 1.2× 353 1.3× 173 1.2× 137 1.0× 40 0.5× 15 754
Leo Kunz Switzerland 12 206 0.7× 198 0.7× 164 1.1× 118 0.9× 131 1.7× 15 664
Elínborg Ostermann Austria 10 318 1.0× 403 1.4× 151 1.0× 97 0.7× 43 0.6× 13 766
Neel I. Nissen Denmark 11 280 0.9× 202 0.7× 89 0.6× 132 1.0× 70 0.9× 18 600
Jurrit Zeilstra Netherlands 6 404 1.3× 369 1.3× 64 0.4× 151 1.1× 47 0.6× 7 639
Katharine D. Grugan United States 9 301 1.0× 286 1.0× 159 1.1× 107 0.8× 29 0.4× 12 585
Gang Xue China 14 282 0.9× 219 0.8× 338 2.3× 104 0.8× 75 1.0× 39 710
Daniëlle Seinstra Netherlands 10 417 1.3× 360 1.3× 69 0.5× 161 1.2× 155 2.0× 12 754

Countries citing papers authored by J. Jason Morton

Since Specialization
Citations

This map shows the geographic impact of J. Jason Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jason Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jason Morton more than expected).

Fields of papers citing papers by J. Jason Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jason Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jason Morton. The network helps show where J. Jason Morton may publish in the future.

Co-authorship network of co-authors of J. Jason Morton

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jason Morton. A scholar is included among the top collaborators of J. Jason Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jason Morton. J. Jason Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Morton, J. Jason, et al.. (2023). Generation of functional thymic organoids from human pluripotent stem cells. Stem Cell Reports. 18(4). 829–840. 24 indexed citations
2.
Morton, J. Jason, Prabha Yadav, Loni Perrenoud, et al.. (2021). Generation of functional human thymic cells from induced pluripotent stem cells. Journal of Allergy and Clinical Immunology. 149(2). 767–781.e6. 23 indexed citations
3.
Keysar, Stephen B., Nathan Gomes, Bettina Miller, et al.. (2020). Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma. Cancer Research. 80(5). 1183–1198. 16 indexed citations
4.
Gomez, Karina E., Fanglong Wu, Stephen B. Keysar, et al.. (2020). Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells. Cancer Research. 80(19). 4185–4198. 138 indexed citations
5.
Dou, Yan, Martin Darvas, Julie Mathieu, et al.. (2020). Development of an IGF1R longevity variant mouse line using CRISPR/Cas9 genome editing. PubMed. 3(1). 1 indexed citations
6.
Morton, J. Jason, et al.. (2020). The humanized mouse: Emerging translational potential. Molecular Carcinogenesis. 59(7). 830–838. 13 indexed citations
7.
Gomez, Karina E., Tugs‐Saikhan Chimed, Carissa M. Thomas, et al.. (2019). Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function. Oral Oncology. 98. 118–124. 14 indexed citations
8.
Keysar, Stephen B., Justin R. Eagles, Bettina Miller, et al.. (2018). Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression. Clinical Cancer Research. 24(12). 2935–2943. 24 indexed citations
9.
Le, Phuong N., Stephen B. Keysar, Bettina Miller, et al.. (2018). Wnt signaling dynamics in head and neck squamous cell cancer tumor‐stroma interactions. Molecular Carcinogenesis. 58(3). 398–410. 58 indexed citations
10.
Morton, J. Jason, Stephen B. Keysar, Loni Perrenoud, et al.. (2018). Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer. Molecular Carcinogenesis. 57(11). 1651–1663. 19 indexed citations
11.
Morton, J. Jason, Gregory Bird, Yosef Refaeli, & Antonio Jimeno. (2016). Humanized Mouse Xenograft Models: Narrowing the Tumor–Microenvironment Gap. Cancer Research. 76(21). 6153–6158. 176 indexed citations
12.
Gan, Gregory N., Cem Altunbas, J. Jason Morton, et al.. (2015). Radiation dose uncertainty and correction for a mouse orthotopic and xenograft irradiation model. International Journal of Radiation Biology. 92(1). 50–56. 2 indexed citations
13.
Gan, Gregory N., Justin R. Eagles, Stephen B. Keysar, et al.. (2014). Hedgehog Signaling Drives Radioresistance and Stroma-Driven Tumor Repopulation in Head and Neck Squamous Cancers. Cancer Research. 74(23). 7024–7036. 59 indexed citations
14.
Bird, Gregory, Patricia A. Estes, J. Jason Morton, et al.. (2014). Expansion of Human and Murine Hematopoietic Stem and Progenitor Cells Ex Vivo without Genetic Modification Using MYC and Bcl-2 Fusion Proteins. PLoS ONE. 9(8). e105525–e105525. 16 indexed citations
15.
Vallath, Sabarinath, Aldo Scarpa, Paul H. Weinreb, et al.. (2014). The integrin αvβ6 is a promising target for the therapy of PDAC: toward phase I trials. Pancreatology. 14(2). e3–e3. 1 indexed citations
16.
Anderson, Ryan T., Stephen B. Keysar, Daniel W. Bowles, et al.. (2013). The Dual Pathway Inhibitor Rigosertib Is Effective in Direct Patient Tumor Xenografts of Head and Neck Squamous Cell Carcinomas. Molecular Cancer Therapeutics. 12(10). 1994–2005. 20 indexed citations
17.
Mehta, Shreya, et al.. (1998). Interleukin-10 stimulates somatostatin gene expression in vitro and in vivo. Gastroenterology. 114. A1004–A1004. 1 indexed citations
18.
Morton, J. Jason, et al.. (1989). Relative Biological Effectiveness of 241 Am Relative to 192 Ir for Continuous Low-Dose-Rate Irradiation of BA1112 Rat Sarcomas. Radiation Research. 119(3). 478–478. 3 indexed citations
19.
Morton, J. Jason, et al.. (1951). The effect of visible light on the development in mice of skin tumors and leukemia induced by carcinogens.. PubMed. 11(7). 559–61. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kanako Yuki Breakdown of academic impact, for papers by Joakim Karlsson Breakdown of academic impact, for papers by Xuemin Lu Breakdown of academic impact, for papers by Leo Kunz Breakdown of academic impact, for papers by Elínborg Ostermann Breakdown of academic impact, for papers by Neel I. Nissen Breakdown of academic impact, for papers by Jurrit Zeilstra Breakdown of academic impact, for papers by Katharine D. Grugan Breakdown of academic impact, for papers by Gang Xue Breakdown of academic impact, for papers by Daniëlle Seinstra
Rankless by CCL
2026